PTGX Deferred Revenue
Protagonist Therapeutics Inc · Deferred Revenue
PTGX Deferred Revenue
Latest reported$9.55Mperiod ending
PTGX FY Deferred Revenue ($0.00 → $9.55M)
Annual deferred revenue
High-resolution chart · PNG
PTGX deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 9,550,000 | |
| 18,891,000 | |
| 0 | |
| 69,000 | |
| 2,500,000 | |
| 17,209,000 | |
| 19,000,000 | |
| 8,223,000 | |
| 31,752,000 | |
| 0 | |
| 0 | |
| 0 |